General Session 1 includes results from EMBER-3 and OlympiA phase III trials
Komal L. Jhaveri, MD; Matteo Lambertini, MD, PhD; and Judy E. Garber, MD, MPH, were among the experts presenting findings from six studies Wednesday during the first General Session of the 2024 San Antonio Breast Cancer Symposium®.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed